High expression of p-mTOR, p-P70S6K and p-4EBP1 correlate with poor outcome in glioblastoma [28], and p-4EBP1 was demonstrated to be a potential prognostic factor in breast cancer and an independent prognostic marker in ovarian cancer [29,30]. Here, RPS6KB1 is linked to ovarian cancer.